FDAFDA · Food and drugs·Recall number D-0219-2019
Contrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90 mg, 120-count bottles, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99
Published November 14, 2018 · Recall initiated: October 5, 2018
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Container packaging defect.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CONTRAVE
- Manufacturer
- Orexigen Therapeutics, Inc.
- Distributor
- Within the United States
- UPC
- 0351267890997
- Lot
- Lot #: ZYCY, Exp. 04/11/2021
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.